Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Type of study
Language
Publication year range
1.
Neurosci Lett ; 485(3): 241-5, 2010 Nov 26.
Article in English | MEDLINE | ID: mdl-20849917

ABSTRACT

Intracerebroventricular (i.c.v.) or intraperitoneal (IP) administration of saredutant (SR48968), an NK2 receptor antagonist, produces anxiolytic-like effects in rodents in a number of animal models of anxiety. NK2 binding sites are present in several limbic structures in rats, including the hippocampus, thalamus, septum and prefrontal cortex, suggesting involvement in the modulation of emotional processes. The current study investigated the behavioral effects of saredutant infused into the ventral hippocampus (VH), a structure associated with cognitive and emotional processes, to clarify the neural substrate underlying the anxiolytic-like effect of the compound. Saredutant (10, 100 or 500 pmol/0.2 µL) was injected bilaterally into the VH of male CD-1 mice tested in the elevated plus-maze and mouse defense test battery (MDTB). Results from the EPM showed that microinjections of 10 pmol/0.2 µL of saredutant increased entries and time spent in the open arms and enhanced end-arm exploration. In the MDTB, saredutant (500 pmol/0.2 µL) decreased vocalizations and increased escape attempts in mice confronted with a rat. Taken together, these results suggest that hippocampal tachykinin mechanisms are involved in the modulation of anxiety and defensive behaviors.


Subject(s)
Anti-Anxiety Agents/pharmacology , Anxiety/psychology , Benzamides/pharmacology , Hippocampus/physiology , Piperidines/pharmacology , Receptors, Neurokinin-2/antagonists & inhibitors , Animals , Anti-Anxiety Agents/administration & dosage , Avoidance Learning/drug effects , Benzamides/administration & dosage , Cats , Escape Reaction/drug effects , Exploratory Behavior/drug effects , Hippocampus/anatomy & histology , Male , Mice , Microinjections , Odorants , Piperidines/administration & dosage , Rats , Rats, Long-Evans , Stereotaxic Techniques
2.
Behav Brain Res ; 176(2): 222-9, 2007 Jan 25.
Article in English | MEDLINE | ID: mdl-17095103

ABSTRACT

The midbrain dorsal periaqueductal gray (DPAG) is part of the brain defensive system involved in active defense reactions to threatening stimuli. Corticotrophin releasing factor (CRF) is a peptidergic neurotransmitter that has been strongly implicated in the control of both behavioral and endocrine responses to threat and stress. We investigated the effect of the nonspecific CRF receptor agonist, ovine CRF (oCRF), injected into the DPAG of mice, in two predator-stress situations, the mouse defense test battery (MDTB), and the rat exposure test (RET). In the MDTB, oCRF weakly modified defensive behaviors in mice confronted by the predator (rat); e.g. it increased avoidance distance when the rat was approached and escape attempts (jump escapes) in forced contact. In the RET, drug infusion enhanced duration in the chamber while reduced tunnel and surface time, and reduced contact with the screen which divides the subject and the predator. oCRF also reduced both frequency and duration of risk assessment (stretch attend posture: SAP) in the tunnel and tended to increase freezing. These findings suggest that patterns of defensiveness in response to low intensity threat (RET) are more sensitive to intra-DPAG oCRF than those triggered by high intensity threats (MDTB). Our data indicate that CRF systems may be functionally involved in unconditioned defenses to a predator, consonant with a role for DPAG CRF systems in the regulation of emotionality.


Subject(s)
Aggression/drug effects , Corticotropin-Releasing Hormone/pharmacology , Escape Reaction/drug effects , Periaqueductal Gray/drug effects , Analysis of Variance , Animals , Behavior, Animal/drug effects , Dose-Response Relationship, Drug , Male , Mice , Motor Activity/drug effects , Rats
SELECTION OF CITATIONS
SEARCH DETAIL